Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis

Conditions: Multiple Sclerosis, Relapsing-Remitting Interventions: Drug: Ozanimod; Drug: Fingolimod; Other: Placebo Sponsors: Celgene Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials